Skip to Content
American Heart Association
Sign-in / Sign-up
Join or Renew
My Local Events
Find out what is happening at your local American Heart
Have an account?
Need an account?
Login with Your Social Identity:
Statements & Guidelines
FDA approves evolocumab, a PCSK9 inhibitor, to treat certain patients with high cholesterol
Congenital Heart Disease: Moving from Adolescence into Adulthood
Best Practices in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: The Transition Process and Medical and Psychosocial Issues
There are over 1 million adults in the United States with congenital heart disease.
Unfortunately, currently less than 30% of these adults see appropriate specialized providers.
A well-planned and executed “transition process” into adulthood for adolescents with congenital heart disease is needed.
Read the full article in
: Preparing Adolescents with Congenital
Heart Disease for Transition to Adulthood by Frank W. Sellke, M.D.
Top Ten Things To Know
Congenital Heart Defects
ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease
Statistical Fact Sheet - Congenital Cardiovascular Defects
AHA Statements on Congenital Heart Defects
Scientific Statement and Guideline Library
Heart and Stroke Statistics – 2011 Update
Become A Member
Join or renew your AHA/ASA Professional Membership
to qualify for members-only awards, and:
• Affiliate with one of 16 Scientific Councils.
• Save on AHA/ASA Scientific Sessions.
• Save on print publications.
• Apply for research funding and not pay a fee
many more membership benefits
Promo code: WDJ008ZZ
Professional Online Network
JOIN OUR NETWORK
Already in the network?